Comparison between Intravenous Injection of Iron Sucrose and Oral Administration of Iron for the Treatment of Iron Deficiency Anemia in Pregnancy

Abstract

The aim of this study was to compare the therapeutic benefits of intravenous iron and oral iron administration for the treatment of iron deficiency anemia (IDA) in pregnancy. A total of 50 patients with gestational age between 25 and 35 weeks with established IDA with Hemoglobin (Hb) 7–9 g/dl were randomized to receive either oral ferrous sulphate 200 mg twice daily or required dose of intravenous iron sucrose 200 mg in 100 ml NS on alternate days. The Hb level, hematocrit, mean corpuscular volume and packed cell volume were measured at recruitment and on 1^st week, 3^rd week and at 37 weeks. Adverse drug reactions were also noted in both the groups. Hb values varied drastically with time between the two groups at 1^st week, 3^rd week and at term. Intravenous iron sucrose helped in treating IDA in pregnancy more effectively than oral iron therapy, without any side effects or reactions.

Keyword: Iron deficiency anemia (IDA), iron sucrose, oral iron therapy

Cite this Article

Yadav V, Nagarathanama R, Prasad N. Comparison between Intravenous Injection of Iron Sucrose and Oral Administration of Iron for the Treatment of Iron Deficiency Anemia in Pregnancy. Research and Reviews: Journal of Surgery. 2016; 5(3): 25–28p.